As at 4 January 2020, the issued share capital of the Company is 35,556,549 ordinary shares of £0.0001.
The directors are interested in a total of 7,894,652 (22.2%).

There are a total of 5,449,998 Share Options over ordinary shares in issue. If all Options were to be exercised, the total issued share capital of the Company would comprise 41,006,547 ordinary shares.

There are 27,502,825 warrants over ordinary shares in issue, all with an exercise price of 2.5p and all with an expiry date of 21 June 2022.

Should a warrant holder exercise all their warrants over ordinary shares by 21 June 2020, the warrant holder will receive one new replacement warrant for each warrant exercised. The new replacement warrants will have an exercise price of 5p and an expiry date of three years following the issue of such replacement warrants.

In the event that all 27,502,825 warrants over ordinary shares are exercised in full by 21 June 2020, the Company would receive funding of £687,570.

In the event that all 27,502,825 new replacement warrants are exercised in the three years following their issuance, the Company would receive further funding of £1,375,141.

There are potentially a maximum of 55,005,650 warrants that could be exercised by 21 June 2023. If all warrants were to be exercised, the total issued share capital of the Company would comprise 90,562,199.

If all outstanding options and warrants were exercised by 21 June 2023, the maximum total issued share capital of the Company would be 96,012,197 ordinary shares.